On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...

WASHINGTON, DC—Use of the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) appears to be a safe and effective option for the treatment of in-stent restenosis, but acute and late ...

PARIS, May 19, 2015 /PRNewswire/ -- Abbott announced today that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1™, which combines the world's first ...

Abbott said it will monitor bioabsorbable stent implantations in Europe, following a high rate of heart attacks in European Absorb GT1 patients, plus a separate FDA safety alert regarding adverse ...

A matched comparison of two disappearing stents, one of which dissolves as early as 1 to 2 years after implantation, suggests the two platforms perform equally well and result in similar clinical ...

Abbott Laboratories ABT received a major boost when the FDA approved its bioresorbable heart stent, Absorb, for the treatment of coronary artery disease in the U.S. Approximately 15 million people in ...

FRESNO, Calif. (KFSN) -- The last time Giacomo Ciabattini walked into Saint Agnes Medical Center in Northeast Fresno, he was in a much bigger hurry. He was having a major cardiac episode on ...

Abbott Laboratories, one of the biggest makers of coronary stents in the world, is halting global sales of a fully absorbable stent that was once hailed as the next big breakthrough in medical devices ...

DENVER -- As new 3- and 4-year data emerged from the ABSORB clinical trials, the FDA updated its cautions to healthcare professionals about continuing risk seen with the first-generation Absorb ...

WASHINGTON (March 18, 2017) -- Patients receiving the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), a dissolving stent to open clogged vessels around the heart, showed outcomes ...

F or nearly two decades, most patients with blocked heart vessels have been treated with metal stents that open clogged arteries and then remain in place for the individual’s lifetime. But after ...